Abstract
Spinal cord injury (SCI) remains one of the most devestating conditions in medicine, particularily due to the loss of productive life years and the high economic burden it places on our society. There are limited therapeutic options available to reduce the morbidity and mortality related to SCI. However, recent work with stem cells in repairing SCI appears to be promising, making this one of the most exciting frontiers in medicine.
A brief review of the mechanisms of SCI is presented. Stem cells from a variety of sources have shown effectiveness in improving motor function after SCI in animals. The pre-clinical use of stem cells in SCI and methods of delivery are discussed. The potential use of granulocyte-colony stimulating factor (G-CSF) to increase the number of stem cells engrafting at the site of injury in order to improve neurological and motor function recovery following SCI is introduced.
G-CSF, through stimulation of lymphohemopoietic stem cells in peripheral blood, can potentially cause repopulation of the SCI region with neural progenitor cells. This allows for improved functional outcomes. More pre-clinical and translational research exploring this possibility is required.
Similar content being viewed by others
References
Akiyama Y., Radtke C., Honmou O., et al. 2002 Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 39:229–236
Begley C. G., Lopez A. F., Nicola N. A., et al. 1986 Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood 68:162–166
Begley C. G., Metcalf D., Nicola N. A. 1987 Purified colony stimulating factors (g-csf and gm-csf) induce differentiation in human hl60 leukemic cells with suppression of clonogenicity. Int. J. Cancer. 39:99–105
Bianco P., Gehron Robey P. 2000 Marrow stromal stem cells. J. Clin. Invest. 105:1663–1668
Bjorklund A., Svendsen C. 1999 Stem cells. Breaking the brain–blood barrier. Nature 397:569–570
Blesch A., Lu P., Tuszynski M. H. 2002 Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res. Bull. 57:833–838
Bodine D. M., Seidel N. E., Orlic D. 1996 Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88:89–97
Bouhy, D. Delayed injection of gm-csf improves functional recovery and promotes axonal regeneration after spinal cord injury. 56th Annual Meeting of American Academy of Neurology, 2004; Suppl 5: A458
Bouhy D., Malgrange B., Multon S., et al. (2006) Delayed gm-csf treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased bdnf expression by endogenous macrophages. FASEB J. 20: 1239–1241
Burgess A. W., Metcalf D. 1980 The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56:947–958
Byrne J. L., Russell N. H. 1998 Peripheral blood stem cell transplants. J. Clin. Pathol. 51:351–355
Campos L., Ambron R. T., Martin J. H. 2004 Bridge over troubled waters. Neuroreporting 15:2691–2694
Cao Q. L., Zhang Y. P., Howard R. M., et al. 2001 Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp. Neurol. 167:48–58
Chapman B. 1999 Transplanting hematopoietic progenitor cells. CAP Today 13:48, 52–56, 58
Chen J., Li Y., Wang L., et al. 2001 Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005–1011
Chopp M., Zhang X. H., Li Y., et al. 2000 Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreporting 11:3001–3005
Chow S. Y., Moul J., Tobias C. A., et al. 2000 Characterization and intraspinal grafting of egf/bfgf-dependent neurospheres derived from embryonic rat spinal cord. Brain Res. 874:87–106
Corti S., Locatelli F., Donadoni C., et al. 2002 Neuroectodermal and microglial differentiation of bone marrow cells in the mouse spinal cord and sensory ganglia. J. Neurosci. Res. 70:721–733
Corti S., Locatelli F., Strazzer S., et al. 2002 Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment. Exp. Neurol. 177:443–452
Demetri G. D., Griffin J. D. 1991 Granulocyte colony-stimulating factor and its receptor. Blood 78:2791–2808
Eglitis M. A., Dawson D., Park K. W., et al. 1999 Targeting of marrow-derived astrocytes to the ischemic brain. Neuroreporting 10:1289–1292
Elfenbein G. J., Sackstein R., Oblon D. J. 2004 Do g-csf mobilized, peripheral blood-derived stem cells from healthy, hla-identical donors really engraft more rapidly than do g-csf primed, bone marrow-derived stem cells? No! Blood Cells Mol. Dis. 32:106–111
Evans R., Wilberger J. 2003 Traumatic Disorders. Philedelphia: Elsevier Science
Faulkner J. R., Herrmann J. E., Woo M. J., et al. 2004 Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24:2143–2155
Frampton J. E., Lee C. R., Faulds D. 1994 Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48:731–760
Fujiwara Y., Tanaka N., Ishida O., et al. 2004 Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett. 366:287–291
Gazitt Y. 2002 Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells. Curr. Opin. Hematol. 9:190–198
Gussoni E., Soneoka Y., Strickland C. D., et al. 1999 Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390–394
Ha Y., Kim Y. S., Cho J. M., et al. 2005 Role of granulocyte-macrophage colony-stimulating factor i preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J. Neurosurg. Spine 2:55–61
Hartung T. 1998 Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr. Opin. Hemat. 5:221–225
Hofstetter C. P., Schwarz E. J., Hess D., et al. (2002) Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. USA 99:2199–2204
Hornig C. R., Busse O., Buettner T., et al. 1985 Ct contrast enhancement on brain scans and blood-csf barrier disturbances in cerebral ischemic infarction. Stroke 16:268–273
Koda M., Nishio Y., Kamada T., et al. 2007 Granulocyte colony-stimulating factor (g-csf) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res. 1149:223–231
Koda M., Okada S., Nakayama T., et al. 2005 Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice. Neuroreporting 16:1763–1767
Konishi Y., Chui D. H., Hirose H., et al. 1993 Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609:29–35
Koshizuka S., Okada S., Okawa A., et al. 2004 Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J. Neuropathol. Exp. Neurol. 63:64–72
Kwon B. K., Tetzlaff W., Grauer J. N., et al. 2004 Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 4:451–464
Lu P., Jones L. L., Snyder E. Y., et al. 2003 Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 181:115–129
Lu D., Mahmood A., Wang L., et al. 2001 Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreporting 12:559–563
Lu C. Z., Xiao B. G. 2006 G-csf and neuroprotection: a therapeutic perspective in cerebral ischaemia. Biochem. Soc. Trans. 34:1327–1333
McDonald J. W., Liu X. Z., Qu Y., et al. 1999 Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5:1410–1412
McKay R. 1997 Stem cells in the central nervous system. Science 276:66–71
Mezey E., Chandross K. J. 2000 Bone marrow: a possible alternative source of cells in the adult nervous system. Eur. J. Pharmacol. 405:297–302
Mezey E., Chandross K. J., Harta G., et al. 2000 Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779–1782
Moore M. A. 1999 “Turning brain into blood”—clinical applications of stem-cell research in neurobiology and hematology. N Engl. J. Med. 341:605–607
Nishio Y., Koda M., Kamada T., et al. 2006 The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. J. Neurosurg. Spine 5:424–433
Nobunaga A. I., Go B. K., Karunas R. B. 1999 Recent demographic and injury trends in people served by the model spinal cord injury care systems. Arch. Phys. Med. Rehabil. 80:1372–1382
Okano H. 2002 Stem cell biology of the central nervous system. J. Neurosci. Res. 69:698–707
Paraplegia A. S. O. 2000 Spinal cord injury: facts and figures at a glance. J. Spinal Cord Med. 23:153–155
Pfeifer K., Vroemen M., Blesch A., et al. 2004 Adult neural progenitor cells provide a permissive guiding substrate for corticospinal axon growth following spinal cord injury. Eur. J. Neurosci. 20:1695–1704
Pittenger M. F., Mackay A. M., Beck S. C., et al. 1999 Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Radtke C., Akiyama Y., Brokaw J., et al. 2004 Remyelination of the nonhuman primate spinal cord by transplantation of h-transferase transgenic adult pig olfactory ensheathing cells. FASEB J. 18:335–337
Russell N. H., McQuaker G., Stainer C., et al. 1998 Stem cell mobilisation in lymphoproliferative diseases. Bone Marrow Transplant. 22:935–940
Saporta S., Kim J. J., Willing A. E., et al. 2003 Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J. Hematother. Stem Cell Res. 12:271–278
Sasaki M., Honmou O., Akiyama Y., et al. 2001 Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia 35:26–34
Schabitz W. R., Kollmar R., Schwaninger M., et al. 2003 Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34:745–751
Schneider A., Kruger C., Steigleder T., et al. 2005 The hematopoietic factor g-csf is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115:2083–2098
Sekhon L. H., Fehlings M. G. 2001 Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26:S2–S12
Setoguchi T., Nakashima K., Takizawa T., et al. 2004 Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express bmp inhibitor. Exp. Neurol. 189:33–44
Shamblott M. J., Axelman J., Littlefield J. W., et al. 2001 Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc. Natl. Acad. Sci. USA 98:113–118
Sheridan W. P., Begley C. G., Juttner C. A., et al. 1992 Effect of peripheral-blood progenitor cells mobilised by filgrastim (g-csf) on platelet recovery after high-dose chemotherapy. Lancet 339:640–644
Shyu W. C., Lin S. Z., Lee C. C., et al. 2006 Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. Cmaj 174:927–933
Sinden J. D., Stroemer P., Grigoryan G., et al. 2000 Functional repair with neural stem cells. Novartis Found. Symp. 231:270–283; discussion 283–278:302–276
Six I., Gasan G., Mura E., et al. 2003 Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur. J. Pharmacol. 458:327–328
Solaroglu I., Cahill J., Jadhav V., et al. 2006 A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 37:1123–1128
Solter D., Gearhart J. 1999 Putting stem cells to work. Science 283:1468–1470
Takahashi T., Kalka C., Masuda H., et al. 1999 Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5:434–438
Takeyama K., Ohto H. 2004 Pbsc mobilization. Transfus. Apheresis Sci. 31:233–243
Thomson J. A., Itskovitz-Eldor J., Shapiro S. S., et al. 1998 Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Urdzikova L., Jendelova P., Glogarova K., et al. 2006 Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J. Neurotrauma. 23:1379–1391
Veizovic T., Beech J. S., Stroemer R. P., et al. 2001 Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 32:1012–1019
Vroemen M., Aigner L., Winkler J., et al. 2003 Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. Eur. J. Neurosci. 18:743–751
Willing A. E., Vendrame M., Mallery J., et al. 2003 Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant. 12:449–454
Acknowledgments
This work, by part, was supported by a grant from F. M. Kirby Foundation. The authors would like to thank Tamara Berezina, MD, PhD, for her help with preparing the histological samples and Marjan Asadollahi, MD, and Trevor Baybutt, BS, for their help with preparing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Divani, A.A., Hussain, M.S., Magal, E. et al. The Use of Stem Cells’ Hematopoietic Stimulating Factors Therapy Following Spinal Cord Injury. Ann Biomed Eng 35, 1647–1656 (2007). https://doi.org/10.1007/s10439-007-9359-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-007-9359-x